Smithfield Foods, the largest pork processor in the country, announced it will not close additional plants as it focuses on ...

Contemporary Amperex Technology Co. Ltd.’s upcoming jumbo listing, which could raise more than $5 billion, is the type of ...

Smithfield Foods could be one of the year's biggest U.S. initial public offerings, with the pork producer planning to raise ...

Falling interest rates and crypto-friendly regulations are stirring talks of a crypto IPO boom. Explore the top crypto IPOs ...

Metsera is aiming to put its weight loss drug MET-097i, which boasts of a longer half-life, through Phase III trials.

Smithfield Foods and its Chinese parent raised around $522 million from the U.S. pork giant's initial public offering after ...

Chinese soda maker Dayao is gearing up for a Hong Kong initial public offering as early as the second half of 2025, people ...

Smithfield Foods does not plan to close more U.S. pork processing plants, Chief Executive Shane Smith said on Tuesday, as the ...

Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

Metsera has set its sights on a hefty $289 million IPO as the next-gen obesity biotech seeks to fund a phase 3 trial of its ...

Chinese banks have been pitching to work on the blockbuster Hong Kong secondary listing of the world’s leading EV battery maker CATL for as little as 0.01 per cent in fees, highlighting cut-throat ...

Ascentage is looking to use the IPO proceeds to advance its Phase III candidates for chronic or small lymphocytic leukemia ...